Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.2650
0.00 (0.00%)
Sep 18, 2026, 3:59 PM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 29.07 million as of September 18, 2026. Its market cap has increased by 147.68% in one year.
Market Cap
29.07M
Enterprise Value
28.82M
Revenue
1.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
ChartMarket Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 29.07M, an increase of 337.74%. That is a compound annual growth rate of 37.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 29.07M | 142.66% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 39.65M |
| Defence Therapeutics | 37.89M |
| Medicenna Therapeutics | 36.92M |
| Telescope Innovations | 36.17M |
| Thiogenesis Therapeutics | 34.99M |
| Resverlogix | 30.99M |
| Onco-Innovations | 30.74M |
| The More Life Company | 27.42M |